Export, investments and sustainability – IBSA at the “Made in Italy Summit” of Il Sole 24 Ore

The Italian pharmaceutical sector – a pillar of the national economy – significantly contributes to the scientific and technological progress of the country, bringing “Made in Italy” to the world through exports of excellence. 

The Pharma session of the “Made in Italy Summit 2024” – organised by Il Sole 24 Ore, Financial Times and Sky TG24 – focused on a crucial topic for the future: the need to promote sustainable practices that do not jeopardise the international competitiveness of companies. A complex balance, especially for an industrial sector that continues to innovate and grow.

Giuseppe Celiberti, General Manager of IBSA Italy, contributed with a speech, during which he reiterated the importance of investing in sustainability without losing sight of productivity and growth. “The pharmaceutical industry has a social responsibility towards its People, the communities where it operates, as well as society and the environment as a whole. For this reason, at IBSA we invest in circular economy practices (for example, by reducing energy consumption and minimising waste in our factories); we are also involved in major redevelopment projects of our offices, such as antares, the new Italian headquarters, designed with a view to sustainability, innovation and beauty”.

Also thanks to the facilities in Lodi and Cassina de’ Pecchi, the company serves the entire Group and exports its products to over 90 countries, including the complex US market, thus confirming the quality and excellence of Italian production.

Another important aspect emerged during the event was the significance of the collaboration between companies, universities and institutions in support of innovation. Giuseppe Celiberti argued that such synergies are critical to the future of the sector, allowing academic research to be transformed into practical solutions capable of responding to the needs of patients globally. Projects such as the development of Filmtec® technology and Nahyco® Hybrid Technology show how an integrated public-private approach can ensure competitiveness, as well as a constant progress of innovation in the scientific field. 

Clear, integrated strategies and continuous investments in innovation and sustainability, without compromising the competitiveness of the sector: this, in summary, is the takeaway message of the Summit. A challenge that IBSA Italy faces with determination, demonstrating that – with a long-term vision and concrete actions – the quality of Made in Italy can remain a value recognised and appreciated on a global level.